Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus

References

• Radic, M., M. Herrmann, J. van der Vlag, and O. P. Rekvig. 2011. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 44: 349–356
   PubMed Web of Science ®Google Scholar
• Diaz, M. 2013. The role of activation-induced deaminase in lupus nephritis. Autoimmunity 46: 115–120
   PubMed Web of Science ®Google Scholar
• Harada, T., V. Kyttaris, Y. Li, et al. 2007. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40: 1–8
   PubMed Web of Science ®Google Scholar
• O'Shea, J. J., R. Lahesmaa, G. Vahedi, et al. 2011. Genomic views of STAT function in CD4 + T helper cell differentiation. Nat. Rev. Immunol. 11: 239–250
   PubMed Web of Science ®Google Scholar
• Battle, T. E., and D. A. Frank. 2002. The role of STATs in apoptosis. Curr. Mol. Med. 2: 381–392
   PubMedGoogle Scholar
• Schindler, C., and C. Plumlee. 2008. Inteferons pen the JAK-STAT pathway. Semin. Cell Dev. Biol. 19: 311–318
   PubMed Web of Science ®Google Scholar
• Hückel, M., U. Schurigt, A. H. Wagner, et al. 2006. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res. Ther. 8: R17
   PubMedGoogle Scholar
• Levy, D. E., and J. E. Darnell Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3: 651–662
   PubMed Web of Science ®Google Scholar
• Kim, H. S., and M. S. Lee. 2007. STAT1 as a key modulator of cell death. Cell Signal 19: 454–465
   PubMed Web of Science ®Google Scholar
• Boisson-Dupuis, S., X. F. Kong, S. Okada, et al. 2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24: 364–378
   PubMed Web of Science ®Google Scholar
• Namjou, B., A. L. Sestak, D. L. Armstrong, et al. 2009. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60: 1085–1095
   PubMed Web of Science ®Google Scholar
• Sandling, J. K., S. Garnier, S. Sigurdsson, et al. 2011. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur. J. Hum. Genet. 19: 479–484
   PubMed Web of Science ®Google Scholar
• Abelson, A. K., A. M. Delgado-Vega, S. V. Kozyrev, et al. 2009. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68: 1746–1753
   PubMed Web of Science ®Google Scholar
• Kanemitsu, S., K. Ihara, A. Saifddin, et al. 2002. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J. Rheumatol. 29: 1183–1188
   PubMed Web of Science ®Google Scholar
• Yeh, H. M., C. Y. Yu, H. C. Yang, et al. 2013. Ubiquitin-specific protease 13 regulates IFN signaling by stabilizing STAT1. J. Immunol. 191: 3328–3336
   PubMed Web of Science ®Google Scholar
• Coit, P., M. Jeffries, N. Altorok, et al. 2013. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4 + T cells from lupus patients. J. Autoimmun. 43: 78–84
   PubMed Web of Science ®Google Scholar
• Panchanathan, R., H. Shen, X. Duan, et al. 2011. Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J. Immunol. 186: 6762–6770
   PubMed Web of Science ®Google Scholar
• Panchanathan, R., X. Duan, H. Shen, et al. 2010. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J. Immunol. 185: 7385–7393
   PubMed Web of Science ®Google Scholar
• Panchanathan, R., H. Liu, H. Liu, et al. 2012. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J. Immunol. 188: 270–278
   PubMed Web of Science ®Google Scholar
• Hadj-Slimane, R., M. K. Chelbi-Alix, M. G. Tovey, and P. Bobé. 2004. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. J. Interferon Cytokine Res. 24: 717–728
   PubMed Web of Science ®Google Scholar
• Dong, J., Q. X. Wang, C. Y. Zhou, et al. 2007. Activation of the STAT1 signaling pathway in lupus nephritis in MRL/lpr mice. Lupus. 16: 101–109
   PubMed Web of Science ®Google Scholar
• Sharabi, A., Z. M. Sthoeger, K. Mahlab, et al. 2009. A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW) F1 mice. Clin. Immunol. 133: 61–68
   PubMed Web of Science ®Google Scholar
• Klinman, D. M., D. Tross, S. Klaschik, et al. 2009. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann. N. Y. Acad. Sci. 1175: 80–88
   PubMed Web of Science ®Google Scholar
• Fujimoto, M., H. Tsutsui, O. Xinshou, et al. 2004. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. 16: 303–314
   PubMed Web of Science ®Google Scholar
• Scholz, J. L., M. A. Oropallo, V. Sindhava, et al. 2013. The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus. Lupus. 22: 350–360
   PubMed Web of Science ®Google Scholar
• Karonitsch, T., E. Feierl, C. W. Steiner, et al. 2009. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum. 60: 1463–1471
   PubMed Web of Science ®Google Scholar
• Kuroiwa, T., R. Schlimgen, G. G. Illei, and D. T. Boumpas. 2003. Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis. Clin. Immunol. 106: 65–72
   PubMed Web of Science ®Google Scholar
• Huang, X., Y. Guo, C. Bao, and N. Shen. 2011. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One 6: e21671
   PubMed Web of Science ®Google Scholar
• Dai, R., Y. Zhang, D. Khan, et al. 2010. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302
   PubMed Web of Science ®Google Scholar
• Lu, M. C., N. S. Lai, H. C. Chen, et al. 2013. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 171: 91–99
   PubMed Web of Science ®Google Scholar
• Tang, Y., X. Luo, H. Cui, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065–1075
   PubMed Web of Science ®Google Scholar
• Martinez-Lostao, L., J. Ordi-Ros, F. Balada, et al. 2007. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus. 16: 483–488
   PubMed Web of Science ®Google Scholar
• Gordon, R. A., G. Grigoriev, A. Lee, et al. 2012. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64: 3119–3128
   PubMed Web of Science ®Google Scholar
• Karonitsch, T., K. von Dalwigk, C. W. Steiner, et al. 2012. Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum. 64: 400–408
   PubMedGoogle Scholar
• Nzeusseu Toukap, A., C. Galant, I. Theate, et al. 2007. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 56: 1579–1588
   PubMed Web of Science ®Google Scholar
• Tsai, M. C., W. J. Chen, M. S. Tsai, et al. 2011. Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats. J. Pineal Res. 51: 233–245
   PubMed Web of Science ®Google Scholar
• Hadj-Slimane, R., M. K. Chelbi-Alix, M. G. Tovey, and P. Bobé. 2004. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. J. Interferon Cytokine Res. 24: 717–728
   PubMed Web of Science ®Google Scholar
• Hofer, M. J., W. Li, P. Manders, et al. 2012. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4 + T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 86: 6932–6946
   PubMed Web of Science ®Google Scholar
• Pulit-Penaloza, J. A., S. V. Scherbik, and M. A. Brinton. 2012. Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation. Virology. 425: 71–81
   PubMed Web of Science ®Google Scholar
• Lu, Y., L. Li, H. Yan, et al. 2013. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. Int. J. Cardiol. 168: 5396--5404
   Google Scholar
• Miyake, K., M. Akahoshi, and H. Nakashima. 2011. Th subset balance in lupus nephritis. J. Biomed. Biotechnol. 2011: 980286
   PubMed Web of Science ®Google Scholar
• Santini, S. M., C. Lapenta, L. Santodonato, et al. 2009. IFN-alpha in the generation of dendritic cells for cancer immunotherapy. Handb. Exp. Pharmacol. 188: 295–317
   Google Scholar
• McCoy, L., I. Tsunoda, and R. S. Fujinami. 2006. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39: 9–19
   PubMed Web of Science ®Google Scholar
• Hale, M. B., P. O. Krutzik, S. S. Samra, et al. 2009. Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One. 4: e6756
   Web of Science ®Google Scholar
• Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226: 41–56
   PubMed Web of Science ®Google Scholar
• Ivashkiv, L. B. 2003. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity 36: 473–479
   PubMed Web of Science ®Google Scholar
• Georg, P., and I. Bekeredjian-Ding. 2012. Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity 45: 579–583
   PubMed Web of Science ®Google Scholar
• Parcina, M., M. Schiller, A. Gierschke, et al. 2009. PDC expressing CD36, CD61 and IL-10 may contribute to propagation of immune tolerance. Autoimmunity 42: 353–355
   PubMed Web of Science ®Google Scholar
• Funae, O., A. Shimada, M. Tokui, et al. 2001. Balance of GAD65-specific IL-10 production and polyclonal Th1-type response in type 1 diabetes. Autoimmunity 34: 45–52
   PubMed Web of Science ®Google Scholar